COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Inotek Pharmaceuticals develops ophthalmic therapeutics for glaucoma, advancing trabodenoson (INO‑8875), a topical eye drop that enhances trabecular‑meshwork outflow via protease upregulation, currently in Phase 2 trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors